Skip to main content
DMAC logo

DMAC

DiaMedica Therapeutics Inc.
$7.13 -0.51 (-6.68%) At close · Jul 16
Market Cap
$384.19M
Shares
53,883,345

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Rick Pauls $2,727,350
Julie Krop $1,707,563
Scott Kellen $1,229,520
Fiscal 2024
Executive Total
Rick Pauls $1,550,985
Lorianne Masuoka $1,174,310
Scott Kellen $813,955
Fiscal 2023
Executive Total
Rick Pauls $1,215,161
Scott Kellen $632,215
Kirsten Gruis $596,083
Julie Daves $533,370
Fiscal 2022
Executive Total
Rick Pauls $1,080,607
Kirsten Gruis $1,004,691
Scott Kellen $563,574
Fiscal 2021
Executive Total
Rick Pauls $1,136,169
Scott Kellen $546,720
Harry Alcorn $545,268
Fiscal 2020
Executive Total
Rick Pauls $878,203
Harry Alcorn $509,065
Scott Kellen $489,303
Fiscal 2019
Executive Total
Harry Alcorn $778,300
Rick Pauls $733,707
Scott Kellen $677,807
Fiscal 2018
Executive Total
Rick Pauls $733,707
Scott Kellen $642,921
Key facts CIK 1401040 CUSIP 25253X207 13F (30d) 3 filings 3 filers Visit website